Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled resources are crucial for advancing products from development to commercial launch. Arranta Bio continues to expand capacity and development and manufacturing services across multiple sites with technology platforms designed to meet the evolving demands of our clients and partners.
| Website | http://www.arrantabio.com |
| Revenue | $19.4 million |
| Employees | 72 (11 on RocketReach) |
| Founded | 2019 |
| Phone | +1 785-760-3128 |
| Technologies |
JavaScript
,
HTML
,
PHP
+27 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Contract Development Manufacturing, Biologics Manufacturing, Cdmo Services, Biologics Cdmo, Biopharmaceutical Manufacturing, Therapeutic Drug Development, Pharmaceutical Cdmo, Drug Manufacturing, Pharmaceutical Development, Process Development, Biotechnology Manufacturing, Innovative Therapies, Drug Substance Manufacturing, Drug Product Manufacturing, Pharmaceutical Outsourcing, Custom Manufacturing, Fill Finish, Clinical Trial Materials |
| Competitors | Danaher Corporation, Lonza, Thermo Fisher Scientific, Sartorius, Merck Group, Pfizer, Geno, Celerion, WuXi AppTec, MedImmune +40 more (view full list) |
Looking for a particular Arranta Bio employee's phone or email?
The Arranta Bio annual revenue was $19.4 million in 2026.
Matthew Ulinski is the Associate Director, S and Op and Supply Chain Compliance of Arranta Bio.
11 people are employed at Arranta Bio.
Arranta Bio is based in Watertown, Massachusetts.